Category Oncology
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Checkpoint Inhibitor Therapy: Immune-related Adverse Event Management
Price: $21.95Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: N1124APublished: Nov 2024Expires: 12/4/2026Sources: Nursing2024DetailsRequired Passing Score: 8/10 (80%)Specialties: Acute Care, Advanced Practice Nursing, Ambulatory Care, Medical-Surgical, Oncology, Primary CareTopics: Checkpoint Inhibitor Therapy , Immune Checkpoint Inhibitors (ICIs) , Immune-Related Adverse Events (irAEs) , Immunotherapy , Oncologic EmergencyMedia:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Advancing Predictive Biomarkers for Colon Cancer Treatment
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1124Published: November 2024Expires: 12/4/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Highlights Promising Treatment Approach for Children with Relapsed/Refractory JMML
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT1024Published: October 2024Expires: 12/4/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Acupuncture for Breast Cancer Patients Undergoing Endocrine Therapy
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0924Published: September 2024Expires: 9/4/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Connection Between Male Infertility & Family Cancer Risk
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0824Published: August 2024Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, Endocrinology, Family Practice, Oncology, Primary Care, UrologyMedia:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Role of Bacteria Subtype in Progression of Colorectal Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0724Published: July 2024Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Childhood Cancer survivors may Benefit from Plant-rich Foods
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0624Published: Jun 2024Expires: 6/5/2026Sources: Oncology TimesDetails -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Explores Durvalumab Plus Ceralasertib in Immunotherapy-Resistant Lung Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
- NM - BON 1.0 CH
- SC - BON 1.0 CH
- WV - BOERN 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0524Published: May 2024Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Media:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Osimertinib + Chemotherapy Improves Survival in Advanced NSCLC
Price: $12.95Credits:
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0424Published: April 2024Expires: 6/5/2026Sources: Oncology TimesDetailsRequired Passing Score: 4/5 (80%)Specialties: Advanced Practice Nursing, OncologyTopics: Cancer , ChemotherapyMedia:
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Breast Cancer in Patients Younger Than 40 Years: Imaging, Assessment, and Management
Price: $49.00Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
- NM - BON 2.0 CH
- SC - BON 2.0 CH
- WV - BOERN 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: PGO0424Published: Apr 2024Expires: 6/5/2026Details